Postoperative patient blood management: transfusion appropriateness in cancer patients.


Journal

Blood transfusion = Trasfusione del sangue
ISSN: 2385-2070
Titre abrégé: Blood Transfus
Pays: Italy
ID NLM: 101237479

Informations de publication

Date de publication:
09 2020
Historique:
received: 18 02 2020
accepted: 11 05 2020
entrez: 15 9 2020
pubmed: 16 9 2020
medline: 7 5 2021
Statut: ppublish

Résumé

While patient blood management (PBM) principles are not specific to cancer patients, their application contains the pathophysiological premises that could also benefit this patient population. In this study, we assessed the effects of implementing a PBM bundle for cancer patients in the postoperative period. The Azienda USL-IRCCS of Reggio Emilia implemented a two-step PBM bundle for the postoperative period of cancer patients hospitalised in the semi-intensive post-surgery (SIPO) ward. Step 1 included seminars and lessons specifically targeting SIPO personnel; Step 2 introduced Points of Care (POCs) for the continuous monitoring of haemoglobin (Radical7, Masimo Corp, Irvine, CA, USA). We conducted 3 audits on 600 cancer patients recruited between 2014 and 2017: Audit 1 on 200 patients before the application of our PBM bundle; Audit 2 after Step 1 on 200 patients; Audit 3 after Step 2 on 200 patients monitored with POCs. Red blood cell (RBC) transfusion appropriateness in the postoperative period was evaluated using the Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) recommendations. RBC transfusion appropriateness in the postoperative period of cancer patients rose from 38% to 75% after seminars, and reached 79% after the introduction of POC. The mean number of RBC units each patient received remained unchanged after training sessions (1.8 units/patient) while the introduction of POCs saw a simultaneous decrease in the number of prescribed units (1.3 units/patient). Our PBM bundle positively impacted RBC transfusion appropriateness in postsurgical cancer patients, both in terms of quality and quantity. A structured PBM programme specifically dedicated to surgical oncology should cover the entire perioperative period and might further improve transfusion appropriateness in these patients. The publication of guidelines on the management of anaemia in surgical oncology should be a priority.

Sections du résumé

BACKGROUND
While patient blood management (PBM) principles are not specific to cancer patients, their application contains the pathophysiological premises that could also benefit this patient population. In this study, we assessed the effects of implementing a PBM bundle for cancer patients in the postoperative period.
MATERIALS AND METHODS
The Azienda USL-IRCCS of Reggio Emilia implemented a two-step PBM bundle for the postoperative period of cancer patients hospitalised in the semi-intensive post-surgery (SIPO) ward. Step 1 included seminars and lessons specifically targeting SIPO personnel; Step 2 introduced Points of Care (POCs) for the continuous monitoring of haemoglobin (Radical7, Masimo Corp, Irvine, CA, USA). We conducted 3 audits on 600 cancer patients recruited between 2014 and 2017: Audit 1 on 200 patients before the application of our PBM bundle; Audit 2 after Step 1 on 200 patients; Audit 3 after Step 2 on 200 patients monitored with POCs. Red blood cell (RBC) transfusion appropriateness in the postoperative period was evaluated using the Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) recommendations.
RESULTS
RBC transfusion appropriateness in the postoperative period of cancer patients rose from 38% to 75% after seminars, and reached 79% after the introduction of POC. The mean number of RBC units each patient received remained unchanged after training sessions (1.8 units/patient) while the introduction of POCs saw a simultaneous decrease in the number of prescribed units (1.3 units/patient).
DISCUSSION
Our PBM bundle positively impacted RBC transfusion appropriateness in postsurgical cancer patients, both in terms of quality and quantity. A structured PBM programme specifically dedicated to surgical oncology should cover the entire perioperative period and might further improve transfusion appropriateness in these patients. The publication of guidelines on the management of anaemia in surgical oncology should be a priority.

Identifiants

pubmed: 32931414
pii: 2020.0048-20
doi: 10.2450/2020.0048-20
pmc: PMC7592164
doi:

Types de publication

Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

359-365

Références

Ann Thorac Surg. 2014 May;97(5):1827-37
pubmed: 24674755
Transfusion. 2017 Sep;57(9):2189-2196
pubmed: 28671296
Blood Transfus. 2016 Jan;14(1):23-65
pubmed: 26710356
Oncologist. 2016 Mar;21(3):327-32
pubmed: 26865590
Blood Transfus. 2011 Jul;9(3):320-35
pubmed: 21627922
Blood Transfus. 2019 Nov;17(6):459-464
pubmed: 31403929
World J Surg Oncol. 2018 Aug 7;16(1):159
pubmed: 30086770
Best Pract Res Clin Anaesthesiol. 2013 Mar;27(1):43-58
pubmed: 23590915
Ann Surg. 2012 Aug;256(2):235-44
pubmed: 22791100
JAMA Surg. 2016 Jun 1;151(6):518-25
pubmed: 26763765
Clin Lab Haematol. 2005 Feb;27(1):1-13
pubmed: 15686502
Accid Emerg Nurs. 2004 Jan;12(1):39-46
pubmed: 14700571
Transfusion. 2018 Oct;58(10):2345-2351
pubmed: 30203500
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv96-iv110
pubmed: 29471514
BMJ Open. 2013 May 02;3(5):
pubmed: 23645909
Cancer Growth Metastasis. 2016 Mar 13;9:1-8
pubmed: 27006592
N Engl J Med. 2017 Sep 28;377(13):1261-1272
pubmed: 28953438

Auteurs

Lucia Merolle (L)

Transfusion Medicine Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Chiara Marraccini (C)

Transfusion Medicine Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Erminia Di Bartolomeo (E)

Transfusion Medicine Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Maria T Montella (MT)

Operation Management Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Thelma A Pertinhez (TA)

Transfusion Medicine Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Department of Medicine and Surgery, University of Parma, Parma, Italy.

Roberto Baricchi (R)

Transfusion Medicine Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Alessandro Bonini (A)

Transfusion Medicine Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH